Download DNB 2016 Dec HEMATOLOGY PAPER 3 Question Paper

Download Diplomate of National Board (DNB) 2016 Dec HEMATOLOGY PAPER 3 Previous Question Paper

FINAL EXAM NATIONAL BOARD OF EXAMINATIONS
DECEMBER 2016
-1-
POSSESSION / USE OF CELL PHONES OR ANY SUCH ELECTRONIC GADGETS IS NOT PERMITTED INSIDE THE
EXAMINATION HALL.
HEMATOLOGY

PAPER ? III
HEMAT/D/16/48/III
Time : 3 hours
Max. Marks : 100

Important instructions:

? Attempt all questions in order.
? Each question carries 10 marks.
? Read the question carefully and answer to the point neatly and legibly.
? Do not leave any blank pages between two answers.
? Indicate the question number correctly for the answer in the margin space.
? Answer all the parts of a single question together.
? Start the answer to a question on a fresh page or leave adequate space between two answers.
? Draw table/diagrams/flowcharts wherever appropriate.

Write short notes on:

1. a) Clinical and laboratory diagnosis of anti-phospholipid antibody
syndrome (APLA).
b) How do you manage a case of recurrent pregnancy loss in a case
of APLA?

5+5
2. In deep vein thrombosis/Pulmonary thromboembolism:
a) How do you manage initially?
b) How do you do transition from initial treatment?
c) How do you select anti-coagulants?
d) How do you monitor and for how long?

3+3+2+2
3. a) Enumerate anti-platelet drugs.
b) Advantages of newer anti-platelet drugs.
c) Role of platelet transfusion in anti-platelet associated bleeding.

2+4+4
4. Discrepancies between genotypic and phenotypic expressions in:
a) Hemoglobinopathies
b) Bleeding disorders.

5+5
5. a) Classify myeloid neoplasms.
b) Mention the mutations in polycythemia vera, essential
thrombocythemia and myelofibrosis
c) What is their potential significance?

4+3+3
6. a) Name thrombopoietic agents.
b) What are their side effects?
c) What is their role in ITP?

2+3+5
7. In acute lymphatic leukemia.
a) Event free survival in children and adults.
b) Treatment related mortality.
c) Long term effects



4+2+4




P.T.O.
FirstRanker.com - FirstRanker's Choice
FINAL EXAM NATIONAL BOARD OF EXAMINATIONS
DECEMBER 2016
-1-
POSSESSION / USE OF CELL PHONES OR ANY SUCH ELECTRONIC GADGETS IS NOT PERMITTED INSIDE THE
EXAMINATION HALL.
HEMATOLOGY

PAPER ? III
HEMAT/D/16/48/III
Time : 3 hours
Max. Marks : 100

Important instructions:

? Attempt all questions in order.
? Each question carries 10 marks.
? Read the question carefully and answer to the point neatly and legibly.
? Do not leave any blank pages between two answers.
? Indicate the question number correctly for the answer in the margin space.
? Answer all the parts of a single question together.
? Start the answer to a question on a fresh page or leave adequate space between two answers.
? Draw table/diagrams/flowcharts wherever appropriate.

Write short notes on:

1. a) Clinical and laboratory diagnosis of anti-phospholipid antibody
syndrome (APLA).
b) How do you manage a case of recurrent pregnancy loss in a case
of APLA?

5+5
2. In deep vein thrombosis/Pulmonary thromboembolism:
a) How do you manage initially?
b) How do you do transition from initial treatment?
c) How do you select anti-coagulants?
d) How do you monitor and for how long?

3+3+2+2
3. a) Enumerate anti-platelet drugs.
b) Advantages of newer anti-platelet drugs.
c) Role of platelet transfusion in anti-platelet associated bleeding.

2+4+4
4. Discrepancies between genotypic and phenotypic expressions in:
a) Hemoglobinopathies
b) Bleeding disorders.

5+5
5. a) Classify myeloid neoplasms.
b) Mention the mutations in polycythemia vera, essential
thrombocythemia and myelofibrosis
c) What is their potential significance?

4+3+3
6. a) Name thrombopoietic agents.
b) What are their side effects?
c) What is their role in ITP?

2+3+5
7. In acute lymphatic leukemia.
a) Event free survival in children and adults.
b) Treatment related mortality.
c) Long term effects



4+2+4




P.T.O.
FINAL EXAM NATIONAL BOARD OF EXAMINATIONS
DECEMBER 2016
-2-
POSSESSION / USE OF CELL PHONES OR ANY SUCH ELECTRONIC GADGETS IS NOT PERMITTED INSIDE THE
EXAMINATION HALL.

HEMATOLOGY

PAPER ? III

8. a) Enumerate the thalassemic syndromes.
b) Importance of screening for thalassemia in antenatal mothers.
c) What are the antenatal diagnostic tests available in different
trimesters of pregnancy?

3+5+2
9. a) Classify myelodysplastic syndromes.
b) Clinical features, pathological factors and differential diagnosis of
myelodysplastic syndromes.

3+(2+2+3)
10. Newer drugs/products in malignant hematology.

10
**********************
FirstRanker.com - FirstRanker's Choice